CVS Health Corp (NYSE: CVS) has a price-to-earnings ratio that is above its average at 17.41x. The stock has a 36-month beta value of 0.59. Opinions on the stock are mixed, with 12 analysts rating it as a “buy,” 7 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for CVS is 1.26B, and at present, short sellers hold a 1.58% of that float. On April 07, 2025, the average trading volume of CVS was 10.97M shares.
CVS) stock’s latest price update
The stock price of CVS Health Corp (NYSE: CVS) has plunged by -5.70 when compared to previous closing price of 67.51, but the company has seen a -5.18% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-04-05 that CVS has been worst hit by the rising healthcare utilization/ medical costs, as observed in the relatively higher medical benefit ratio in FQ4’24/ FY2024 compared to its peers. Even so, we believe that FY2024 (and maybe FY2025) are likely to be its trough years, as the management offers promising guidance and the consensus raises forward estimates. Despite industry-wide issues, CVS remains well positioned to weather through the near-term uncertainties, thanks to the pricing increases and the stable balance sheet health.
CVS’s Market Performance
CVS’s stock has fallen by -5.18% in the past week, with a monthly drop of -2.44% and a quarterly rise of 43.96%. The volatility ratio for the week is 3.27% while the volatility levels for the last 30 days are 2.73% for CVS Health Corp The simple moving average for the last 20 days is -4.65% for CVS stock, with a simple moving average of 9.14% for the last 200 days.
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with Leerink Partners repeating the rating for CVS by listing it as a “Outperform.” The predicted price for CVS in the upcoming period, according to Leerink Partners is $75 based on the research report published on February 13, 2025 of the current year 2025.
CVS Trading at 0.65% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.42% of loss for the given period.
Volatility was left at 2.73%, however, over the last 30 days, the volatility rate increased by 3.27%, as shares sank -4.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.28% upper at present.
During the last 5 trading sessions, CVS fell by -5.18%, which changed the moving average for the period of 200-days by +4.21% in comparison to the 20-day moving average, which settled at $66.76. In addition, CVS Health Corp saw 41.81% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from Clark James David, who sale 7,513 shares at the price of $66.35 back on Mar 05 ’25. After this action, Clark James David now owns 8,394 shares of CVS Health Corp, valued at $498,488 using the latest closing price.
Clark James David, the Officer of CVS Health Corp, proposed sale 7,513 shares at $66.35 during a trade that took place back on Mar 05 ’25, which means that Clark James David is holding shares at $498,489 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- 0.02 for the present operating margin
- 0.14 for the gross margin
The net margin for CVS Health Corp stands at 0.01. The total capital return value is set at 0.05. Equity return is now at value 6.07, with 1.78 for asset returns.
Based on CVS Health Corp (CVS), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.11. The debt to equity ratio resting at 1.1. The interest coverage ratio of the stock is 2.88.
Currently, EBITDA for the company is 13.7 billion with net debt to EBITDA at 5.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.41. The receivables turnover for the company is 10.22for trailing twelve months and the total asset turnover is 1.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.81.
Conclusion
To sum up, CVS Health Corp (CVS) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
